Skip to content
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Contact Us
Menu
  • About Us
    • Management
    • Board of Directors
    • Clinical and Scientific Advisory Board
  • Careers
  • Lead Technology
  • Publications
  • Investors
  • Contact Us
Search
Close
Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

Vasomune Therapeutics is at the 38th J.P. Morgan Healthcare Conference

  • Post author:Shahid Ahmad
  • Post published:January 15, 2020
  • Post category:Uncategorized
JP Morgan Healthcare Conference 2020

Vasomune Therapeutics is currently attending the 38TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

You Might Also Like

Learn More About Vasomune’s Partnership with University of Iowa Pharmaceuticals’ COVID-19 Drug Manufacturing

Learn More About Vasomune’s Partnership with University of Iowa Pharmaceuticals’ COVID-19 Drug Manufacturing

August 18, 2020
The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS)

The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS)

March 20, 2020
A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

June 13, 2015

Recent Posts

  • Vasomune and AnGes Announce First Patient Enrolled in Phase 2a Clinical Study Evaluating AV-001 for the Treatment of Severe COVID-19 Disease
  • Vasomune Announces Government Financial Support for the Development of COVID-19 Therapeutic
  • Vasomune Announces Preliminary Positive Phase 1 Clinical Trial Results for Vascular Normalization Therapy
  • Vasomune is Pleased to Announce the Government of Canada’s Investment in AV-001 Targeting COVID-19
  • Vasomune Announces Initiation of the First-in-Human Clinical Trial of a Potential Vascular Normalization COVID-19 Treatment

Recent Comments

    Archives

    • January 2022
    • November 2021
    • March 2021
    • December 2020
    • November 2020
    • August 2020
    • May 2020
    • March 2020
    • February 2020
    • January 2020
    • August 2018
    • December 2017
    • June 2015

    Categories

    • Press Release
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    About

    Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

    Vasomune Therapeutics 2020 © All Rights Reserved.